Michael Mason, EVP, CFO & Treasurer at Karyopharm Therapeutics Inc. (KPTI), sold 2,545 shares at $1.32 ($3K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Seasonal sale ($3k) by EVP, CFO & Treasurer — this insider has traded KPTI in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |
| KPTI | SELL | 2023-09-05 | $9K | — | Filing → |